These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25580750)

  • 1. Pediatric dyslipidemia: recommendations for clinical management.
    Wilson DP; McNeal C; Blackett P
    South Med J; 2015 Jan; 108(1):7-14. PubMed ID: 25580750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol].
    Brea Hernando ÁJ
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():3-6. PubMed ID: 25043539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multimodal therapy of dyslipidemia].
    Stahn A; Hanefeld M
    Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
    Flink L; Underberg JA; Newman JD; Gianos E
    Curr Atheroscler Rep; 2015 Apr; 17(4):494. PubMed ID: 25690588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid management--treatment goal and strategy].
    Koshiyama H
    Nihon Rinsho; 2006 Nov; 64(11):2102-6. PubMed ID: 17087303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Morrison CC; Dunn J; Nguyen M; Blasi PR; Whitlock EP
    JAMA; 2016 Aug; 316(6):634-44. PubMed ID: 27532918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids and Cerebrovascular Disease: Research and Practice.
    Yaghi S; Elkind MS
    Stroke; 2015 Nov; 46(11):3322-8. PubMed ID: 26451029
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update dyslipidemia].
    Parhofer KG
    Internist (Berl); 2013 Sep; 54(9):1089-103. PubMed ID: 23928724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid-lowering medications for children and adolescents.
    Miller ML; Wright CC; Browne B
    J Clin Lipidol; 2015; 9(5 Suppl):S67-76. PubMed ID: 26343214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastroenterological aspects of atherosclerosis].
    Zvenigorodskaia LA; Samsonova NG; Efremov LI; Cherkashova EA; Lazebnik LB
    Eksp Klin Gastroenterol; 2011; (2):31-6. PubMed ID: 21560640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.